CUSIP 74366E102COMPTGXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
311 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 9.72M | $848.60M | +311.8K | Added |
| 2 | Farallon Capital Management LLC | 6.14M | $536.62M | −52.0K | Reduced |
| 3 | Vanguard Group Inc | 5.41M | $472.83M | +1.16M | Added |
| 4 | Rtw Investments, LP | 5.06M | $441.86M |
| −697.2K |
| Reduced |
| 5 | State Street Corp | 3.20M | $279.46M | +33.9K | Added |
| 6 | Wellington Management Group LLP | 3.17M | $276.99M | +1.26M | Added |
| 7 | Ubs Group AG | 2.77M | $241.93M | +874.0K | Added |
| 8 | Janus Henderson Group PLC | 2.65M | $231.35M | +1.55M | Added |
| 9 | Johnson & Johnson | 2.45M | $213.91M | 0 | Held |
| 10 | Invesco Ltd. | 1.57M | $136.94M | +564.1K | Added |
See every fund holding Protagonist Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders